Biotechnology and IT/Semiconductors lead with multiple strong buy ratings over the past three days. Biotech sees seven strong buys (CMPX, IRD, EYPT), while IT/Semiconductors have four, including AMAT and NTAP. Oil & Gas (CTRA, APA) and Retail (TSCO, KSS) also show strength. Average target upsides suggest continued momentum. However, several biotech and pharma names like ARGX and NVO faced downgrades, signaling caution in select growth areas.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.